Nathalie Rieser
Postdoctoral Research Fellow at Johns Hopkins Center for Psychedelic and Consciousness Research
Data updated
Research Footprint
Nathalie Rieser appears in 6 tracked papers (2021–2026), most studied alongside Psilocybin and Placebo, across Alcohol Use Disorder (AUD), Substance Use Disorders (SUD) and Neuroimaging & Brain Measures.
Most-cited paper: Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial (337 citations).
Frequent co-authors: Katrin Preller, Franz Vollenweider and Marcus Herdener.
Background & Research
Nathalie M. Rieser received her M.Sc. in Cognitive Psychology and Cognitive Neuroscience from the University of Zurich and later completed her PhD there after research experience in Switzerland and the Netherlands. She is now a postdoctoral research fellow at Johns Hopkins, where her work focuses on altered states of consciousness in healthy volunteers and patients.
Key Impact
She studies how pharmacologically and non-pharmacologically induced altered states of consciousness affect the brain, contributing to clinical and mechanistic psychedelic research.
Collaboration Network
5 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Nathalie Rieser is associated with.